Literature DB >> 28617429

Comparison between Bilistick System and transcutaneous bilirubin in assessing total bilirubin serum concentration in jaundiced newborns.

C Greco1, I F Iskander2, D M Akmal2, S Z El Houchi2, D A Khairy2, G Bedogni3, R P Wennberg4, C Tiribelli1,3, C D Coda Zabetta1.   

Abstract

OBJECTIVE: To compare the performance and accuracy of the JM-103 transcutaneous bilirubinometer and Bilistick System in measuring total serum bilirubin for the early identification of neonatal hyperbilirubinemia. STUDY
DESIGN: The study was performed on 126 consecutive term and near-term (⩾36 weeks' gestational age) jaundiced newborns in Cairo University Children Hospital NICU, Egypt. Total serum bilirubin was assayed concurrently by the clinical laboratory and Bilistick System and estimated using the JM-103 transcutaneous bilirubin instrument. Bland-Altman analysis was used to evaluate the agreement between determinations. RESULT: The limits of agreement of the Bilistick System (-5.8 to 3.3 mg dl-1) and JM-103 system (-5.4 to 6.0 mg dl-1) versus the clinical laboratory results were similar.
CONCLUSION: The Bilistick System is an accurate alternative to transcutaneous (TcB) determination for early diagnosis and proper management of the neonatal jaundice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28617429     DOI: 10.1038/jp.2017.94

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  26 in total

1.  Severe hyperbilirubinaemia and kernicterus: more caution is needed in newborn jaundice surveillance.

Authors:  N M Allen; F Mohammad; A Foran; D Corcoran; T Clarke
Journal:  Ir Med J       Date:  2009 Jul-Aug

2.  Transcutaneous bilirubin measurement at the time of hospital discharge in a multiethnic newborn population.

Authors:  Douglas M Campbell; Karoon C Danayan; Valleverdina McGovern; Sohail Cheema; Brenda Stade; Michael Sgro
Journal:  Paediatr Child Health       Date:  2011-03       Impact factor: 2.253

3.  Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.

Authors:  Rasha Gamaleldin; Iman Iskander; Iman Seoud; Hanan Aboraya; Aleksandr Aravkin; Paul D Sampson; Richard P Wennberg
Journal:  Pediatrics       Date:  2011-09-12       Impact factor: 7.124

4.  Bilistick: a low-cost point-of-care system to measure total plasma bilirubin.

Authors:  C D Coda Zabetta; I F Iskander; C Greco; C Bellarosa; S Demarini; C Tiribelli; R P Wennberg
Journal:  Neonatology       Date:  2012-12-22       Impact factor: 4.035

5.  Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes.

Authors:  A K Brown; K Damus; M H Kim; K King; R Harper; D Campbell; K A Crowley; M Lakhani; N Cohen-Addad; R Kim; A Harin
Journal:  J Perinat Med       Date:  1999       Impact factor: 1.901

6.  Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia.

Authors:  V K Bhutani; G R Gourley; S Adler; B Kreamer; C Dalin; L H Johnson
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

7.  Discrepancies between transcutaneous and serum bilirubin measurements.

Authors:  James A Taylor; Anthony E Burgos; Valerie Flaherman; Esther K Chung; Elizabeth A Simpson; Neera K Goyal; Isabelle Von Kohorn; Nui Dhepyasuwan
Journal:  Pediatrics       Date:  2015-01-19       Impact factor: 7.124

Review 8.  Early postnatal discharge from hospital for healthy mothers and term infants.

Authors:  S Brown; R Small; B Faber; A Krastev; P Davis
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.

Authors:  Bolajoko O Olusanya; Tinuade A Ogunlesi; Praveen Kumar; Nem-Yun Boo; Iman F Iskander; Maria Fernanda B de Almeida; Yvonne E Vaucher; Tina M Slusher
Journal:  BMC Pediatr       Date:  2015-04-12       Impact factor: 2.125

10.  The value of bilicheck® as a screening tool for neonatal jaundice in the South of iran.

Authors:  Fariba Hemmati; Neamat Allah Kiyani Rad
Journal:  Iran J Med Sci       Date:  2013-06
View more
  7 in total

Review 1.  Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.

Authors:  Catherine E Majors; Chelsey A Smith; Mary E Natoli; Kathryn A Kundrod; Rebecca Richards-Kortum
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

Review 2.  Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Authors:  Christian V Hulzebos; Libor Vitek; Carlos D Coda Zabetta; Aleš Dvořák; Paul Schenk; Eline A E van der Hagen; Christa Cobbaert; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2021-05-04       Impact factor: 3.756

3.  Point-of-care device to diagnose and monitor neonatal jaundice in low-resource settings.

Authors:  Pelham A Keahey; Mathieu L Simeral; Kristofer J Schroder; Meaghan M Bond; Prince J Mtenthaonnga; Robert H Miros; Queen Dube; Rebecca R Richards-Kortum
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

4.  Agreement test of transcutaneous bilirubin and bilistick with serum bilirubin in preterm infants receiving phototherapy.

Authors:  Rinawati Rohsiswatmo; Hanifah Oswari; Radhian Amandito; Hikari Ambara Sjakti; Endang Windiastuti; Rosalina Dewi Roeslani; Indrayady Barchia
Journal:  BMC Pediatr       Date:  2018-09-29       Impact factor: 2.125

5.  Diagnostic Performance Analysis of the Point-of-Care Bilistick System in Identifying Severe Neonatal Hyperbilirubinemia by a Multi-Country Approach.

Authors:  Chiara Greco; Iman F Iskander; Salma Z El Houchi; Rinawati Rohsiswatmo; Lily Rundjan; Williams N Ogala; Akinyemi O D Ofakunrin; Luciano Moccia; Nguyen Thi Xuan Hoi; Giorgio Bedogni; Claudio Tiribelli; Carlos D Coda Zabetta
Journal:  EClinicalMedicine       Date:  2018-07-17

Review 6.  Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders.

Authors:  Steven M Shapiro; Sean M Riordan
Journal:  Pediatr Res       Date:  2019-10-03       Impact factor: 3.756

7.  Laboratory validation and field usability assessment of a point-of-care test for serum bilirubin levels in neonates in a tropical setting.

Authors:  Laurence Thielemans; Ahmar Hashmi; Dah Dah Priscilla; Moo Kho Paw; Tekel Pimolsorntong; Thatsanun Ngerseng; Bart Van Overmeire; Stephane Proux; François Nosten; Rose McGready; Verena I Carrara; Germana Bancone
Journal:  Wellcome Open Res       Date:  2018-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.